KPIs & Operating Metrics(New)
Growth Metrics

Bausch Health Companies (BHC) EPS (Weighted Average and Diluted) (2016 - 2025)

Bausch Health Companies (BHC) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with -$0.3 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 220.0% to -$0.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.42 through Dec 2025, up 450.0% year-over-year, with the annual reading at $0.42 for FY2025, 423.08% up from the prior year.
  • EPS (Weighted Average and Diluted) hit -$0.3 in Q4 2025 for Bausch Health Companies, down from $0.48 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.1 in Q3 2022 to a low of -$1.71 in Q1 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.23 across 5 years, with a median of -$0.16 in 2024.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 665.0% in 2022 and later surged 1233.33% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.2 in 2021, then plummeted by 665.0% to -$1.13 in 2022, then skyrocketed by 91.15% to -$0.1 in 2023, then surged by 350.0% to $0.25 in 2024, then plummeted by 220.0% to -$0.3 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for BHC at -$0.3 in Q4 2025, $0.48 in Q3 2025, and $0.4 in Q2 2025.